We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUN icon
1026
Cedar Fair
FUN
$1.67B
$7.07M 0.01%
148,243
-5,180
-3% -$268K
MDB icon
1027
MongoDB
MDB
$32.1B
$7.07M 0.01%
46,484
+31,480
+210% +$4.57M
CXO
1028
DELISTED
CONCHO RESOURCES INC.
CXO
$7.07M 0.01%
68,507
-19,018
-22% -$2.05M
GHY
1029
PGIM Global High Yield Fund
GHY
$483M
$7.07M 0.01%
489,036
-108,246
-18% -$1.52M
TNDM icon
1030
Tandem Diabetes Care
TNDM
$1.56B
$7.05M 0.01%
109,214
+88,532
+428% +$5.71M
CNQ icon
1031
Canadian Natural Resources
CNQ
$93.8B
$7.04M 0.01%
534,712
-259,808
-33% -$3.57M
ALE
1032
DELISTED
Allete
ALE
$7.03M 0.01%
84,523
+579
+0.7% +$47.7K
QQQX icon
1033
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.49B
$7.03M 0.01%
314,107
-4,081
-1% -$91.3K
NNN icon
1034
NNN REIT
NNN
$8.99B
$7.03M 0.01%
132,544
+20,341
+18% +$1.09M
PAVE icon
1035
Global X US Infrastructure Development ETF
PAVE
$14.4B
$7M 0.01%
429,658
-9,975
-2% -$159K
ICPT
1036
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.99M 0.01%
87,849
+15,019
+21% +$1.34M
BEAT
1037
DELISTED
BioTelemetry, Inc.
BEAT
$6.98M 0.01%
145,016
-10,201
-7% -$536K
FLO icon
1038
Flowers Foods
FLO
$1.57B
$6.98M 0.01%
299,913
-90,934
-23% -$2.01M
VOYA icon
1039
Voya Financial
VOYA
$9.19B
$6.94M 0.01%
125,511
+8,811
+8% +$472K
AMH icon
1040
American Homes 4 Rent
AMH
$12.5B
$6.94M 0.01%
285,310
-42,470
-13% -$1.02M
MRVL icon
1041
Marvell Technology
MRVL
$196B
$6.92M 0.01%
289,851
-120,213
-29% -$2.81M
PWV icon
1042
Invesco Large Cap Value ETF
PWV
$1.76B
$6.92M 0.01%
187,760
-4,248
-2% -$154K
MGU
1043
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
$6.91M 0.01%
292,112
+68,522
+31% +$1.56M
NOV icon
1044
NOV
NOV
$7B
$6.9M 0.01%
310,546
-87,705
-22% -$2.12M
KLIC icon
1045
Kulicke & Soffa
KLIC
$4.78B
$6.89M 0.01%
305,502
+3,154
+1% +$69.3K
OLED icon
1046
Universal Display
OLED
$4.19B
$6.88M 0.01%
36,586
+4,406
+14% +$733K
GOLF icon
1047
Acushnet Holdings
GOLF
$5.45B
$6.87M 0.01%
261,741
+2,642
+1% +$65.5K
EA
1048
DELISTED
Electronic Arts
EA
$6.87M 0.01%
67,803
-15,144
-18% -$1.44M
TFI icon
1049
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
$6.86M 0.01%
136,866
+5,736
+4% +$285K
SAGE
1050
DELISTED
Sage Therapeutics
SAGE
$6.85M 0.01%
37,391
+4,284
+13% +$731K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.